DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $644,646 | -52.6% | 71,947 | -40.5% | 0.00% | -50.0% |
| Q2 2023 | $1,359,630 | +117.5% | 120,856 | +122.7% | 0.00% | +100.0% |
| Q1 2023 | $625,132 | +324.9% | 54,265 | +327.5% | 0.00% | – |
| Q4 2022 | $147,135 | -8.7% | 12,695 | 0.0% | 0.00% | – |
| Q3 2022 | $161,227 | +101.5% | 12,695 | +8.5% | 0.00% | – |
| Q2 2022 | $80,000 | -29.2% | 11,698 | 0.0% | 0.00% | – |
| Q1 2022 | $113,000 | -18.7% | 11,698 | 0.0% | 0.00% | – |
| Q4 2021 | $139,000 | -26.8% | 11,698 | -0.0% | 0.00% | – |
| Q3 2021 | $190,000 | -22.8% | 11,699 | 0.0% | 0.00% | – |
| Q2 2021 | $246,000 | – | 11,699 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |